Saudi Arabia Over The Counter Drugs Market Demand, Size and Competitive Analysis | TechSci Research

Saudi Arabia Over The Counter Drugs Market was valued at USD 1154.62 Million in 2023 and is expected to reach USD 1820.30 Million by 2029 with a CAGR of 7.84% during the forecast period. <table><tr><td>Pages</td><td>80</td></tr> <tr><td>Market Size</td><td>2023: USD 1154.62 Million</td></tr> <tr><td>Forecast Market Size</td><td>2029: USD 1820.30 Million</td></tr> <tr><td>CAGR</td><td>2024-2029: 7.84%</td></tr> <tr><td>Fastest Growing Segment</td><td>Vitamins, Mineral, and Supplements (VMS)</td></tr> <tr><td>Largest Market</td><td>Central Region</td></tr> <tr><td>Key Players</td><td>1.Novartis Saudi Arabia2.Pfizer Saudi Limited Corporate3.Glenmark Saudi Arabia4.Sitco Pharma Co5.CAD Middle East Pharmaceutical Industries LLC6.Sudair Pharmaceutical Company7.Tabuk Pharmaceuticals Manufacturing Co.8.Jamjoom Pharmaceuticals Co9.GSK Saudi Arabia10.AstraZeneca Saudi Arabia</td></tr> </table>

沙特阿拉伯非处方药物市场在2023年价值达到11.5562亿美元，预计到2029年将增至18.203亿美元，在预测期内，年复合增长率预计为7.84%。

<table>
<tr>
<td>页数</td>
<td>80</td>
</tr>
<tr>
<td>市场规模</td>
<td>2023年：11.5562亿美元</td>
</tr>
<tr>
<td>预测市场规模</td>
<td>2029年：18.203亿美元</td>
</tr>
<tr>
<td>年复合增长率</td>
<td>2024-2029年：7.84%</td>
</tr>
<tr>
<td>增长最快的细分市场</td>
<td>维生素、矿物质和补充剂（VMS）</td>
</tr>
<tr>
<td>最大市场</td>
<td>中部地区</td>
</tr>
<tr>
<td>主要参与者</td>
<td>1.诺华沙特阿拉伯2.辉瑞沙特有限企业3.格伦马克沙特阿拉伯4.锡托药业公司5.CAD中东制药工业有限公司6.苏代尔制药公司7.塔布克制药有限公司8.贾姆朱姆制药公司9.葛兰素史克沙特阿拉伯10.阿斯利康沙特阿拉伯</td>
</tr>
</table>